Antithrombotic Strategy in Patients With AF and Recent ACS or PCI: Primary Results of the AUGUSTUS Trial – American College of Cardiology
Introduction The optimal antithrombotic strategy for patients with atrial fibrillation (AF) with acute coronary syndrome (ACS) and/or recent percutaneous coronary intervention (PCI) can be challenging. Although dual antiplatelet therapy (DAPT) is indicated for secondary prevention of coronary events and to protect against stent thrombosis, it is not indicated for…
